Senhwa Biosciences
Senhwa Biosciences Logo
About Senhwa Biosciences
Senhwa Biosciences Inc is a clinical-stage biotechnology company specializing in the research and development of innovative therapies for cancer. The company focuses on next-generation DNA Damage Response (DDR) therapeutics, with its main compounds, CX-5461 and CX-4945, undergoing phase I/II clinical trials in multiple countries. Senhwa Biosciences aims to advance first-in-class small molecule drugs for cancer treatment and serves patients worldwide from its headquarters in Taiwan.
Address
No. 225, Peihsin Road, 10th Floor Section 3 Hsintien District
New Taipei City, 23143
Taiwan
Year founded
2013
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
